Self‐Delivering Nanodrugs Developed via Small‐Molecule‐Directed Assembly and Macrophage Cloaking for Sonodynamic‐Augmented Immunotherapy
Authors:
- 22 May 2022
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (16) , e2102770
Abstract
The self‐delivery of sonosensitizers and immunomodulators to tumor areas, which is highly recommended for enhancing sonodynamic immunotherapy, remains a challenge. Herein, a self‐delivering nanodrug (HB‐NLG8189, drug loading: ≈100 wt%) is developed by the small‐molecule self‐assembly of "HB" (a new clinical photosensitizer) and NLG8189 (indoleamine‐(2,3)‐dioxygenase (IDO) pathway inhibitor) for sonodynamic‐augmented immunotherapy; this preparation method ensures the absence of excipient‐related toxicity and immunogenicity. To evade immune recognition and prolong the circulation time, the HB‐NLG8189 nanodrugs are camouflaged using macrophage cell membranes (MPCMs). The constructed HB‐NLG8189@MPCM nanodrugs show an ability to preferentially accumulate within tumors. Upon ultrasound triggering, the HB‐NLG8189@MPCM is able to generate reactive oxygen species efficiently for robust sonodynamic therapy; it induces immunogenic cell death, initiates an antitumor immune response to activate tumor‐specific effector T cells, and promotes the secretion of inflammatory cytokines. The concomitant delivery of NLG8189 reverses the immunosuppressive tumor microenvironment by restraining IDO‐1 activation and the intratumoral infiltration of regulatory T cells. Sonodynamic‐augmented immunotherapy with HB‐NLG8189@MPCM significantly inhibits the growth of both primary and distant tumors with little systemic toxicity. The biomimetic self‐delivery nanodrug provides a promising paradigm for improving sonodynamic immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (81773770, 81772893, 61905248, 62005284)
- Natural Science Foundation of Fujian Province (2020J011220)
This publication has 59 references indexed in Scilit:
- Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast CancerACS Nano, 2016
- The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respirationNature Communications, 2016
- Recent progress in development of new sonosensitizers for sonodynamic cancer therapyDrug Discovery Today, 2014
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast CancerThe Journal of Immunology, 2013
- Indoleamine 2,3 dioxygenase and metabolic control of immune responsesTrends in Immunology, 2013
- Immunogenic cell death and DAMPs in cancer therapyNature Reviews Cancer, 2012
- HMGB1 and RAGE in Inflammation and CancerAnnual Review of Immunology, 2010
- Ki67 in breast cancer: prognostic and predictive potentialThe Lancet Oncology, 2010
- CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesityNature Medicine, 2009
- Cytokines and their relationship to the symptoms and outcome of cancerNature Reviews Cancer, 2008